AAAAAA
Results:
1-25
|
Results: 25
Authors:
MILLER AA
TOLLEY EA
NIELL HB
Citation: Aa. Miller et al., THERAPEUTIC DRUG-MONITORING OF 21-DAY ORAL ETOPOSIDE IN PATIENTS WITHADVANCED NONSMALL CELL LUNG-CANCER, Clinical cancer research, 4(7), 1998, pp. 1705-1710
Authors:
BERNARDONI R
MILLER AA
GIANGRANDE A
Citation: R. Bernardoni et al., GLIAL DIFFERENTIATION DOES NOT REQUIRE A NEURAL GROUND-STATE, Development, 125(16), 1998, pp. 3189-3200
Authors:
LILENBAUM RC
MILLER AA
BATIST G
BERNARD S
HOLLIS DR
ROSNER GL
EGORIN MJ
SCHILSKY RL
RATAIN MJ
Citation: Rc. Lilenbaum et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CONTINUOUS-INFUSION TOPOTECAN INCOMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3302-3309
Authors:
MILLER AA
BERNARDONI R
GIANGRANDE A
Citation: Aa. Miller et al., POSITIVE AUTOREGULATION OF THE GLIAL PROMOTING FACTOR GLIDE GCM/, EMBO journal (Print), 17(21), 1998, pp. 6316-6326
Authors:
MILLER AA
ROSNER GL
RATAIN MJ
HOLLIS DR
GREEN MR
SCHILSKY RL
Citation: Aa. Miller et al., PHARMACOLOGY OF 21-DAY ORAL ETOPOSIDE GIVEN IN COMBINATION WITH IV CISPLATIN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-9062), Clinical cancer research, 3(5), 1997, pp. 719-725
Authors:
NIELL HB
MILLER AA
CLAMON GH
PERRY MC
CRAWFORD J
GREEN MR
Citation: Hb. Niell et al., A PHASE-II STUDY EVALUATING THE EFFICACY OF CARBOPLATIN, ETOPOSIDE, AND PACLITAXEL WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH STAGE-IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER AND EXTENSIVE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 130-134
Authors:
ROBERT F
CHEN S
MILLER AA
LEE BC
MOLTHROP DC
WHEELER RH
Citation: F. Robert et al., PHASE-I AND PHARMACOLOGICAL STUDY OF 7-DAY AND 21-DAY CONTINUOUS ETOPOSIDE INFUSION IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 459-465
Authors:
ROBERT F
MOLTHROP DC
MILLER AA
LEE BC
CHEN S
WHEELER RH
Citation: F. Robert et al., PROLONGED INFUSION OF ETOPOSIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, American journal of clinical oncology, 19(5), 1996, pp. 483-486
Authors:
MILLER AA
LIPTON A
HENDERSON IC
NAVARI R
MULAGHA MT
COOPER J
Citation: Aa. Miller et al., FADROZOLE HYDROCHLORIDE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(4), 1996, pp. 789-793
Authors:
MILLER AA
MAUER AM
TOLLEY EA
Citation: Aa. Miller et al., DOSING OF ORAL ETOPOSIDE NORMALIZED FOR BODY-SURFACE AREA, Cancer investigation, 13(5), 1995, pp. 487-491
Authors:
LILENBAUM RC
RATAIN MJ
MILLER AA
HARGIS JB
HOLLIS DR
ROSNER GL
OBRIEN SM
BREWSTER L
GREEN MR
SCHILSKY RL
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 13(9), 1995, pp. 2230-2237
Authors:
MILLER AA
HERNDON JE
HOLLIS DR
ELLERTON J
LANGLEBEN A
RICHARDS F
GREEN MR
Citation: Aa. Miller et al., SCHEDULE DEPENDENCY OF 21-DAY ORAL VERSUS 3-DAY INTRAVENOUS ETOPOSIDEIN COMBINATION WITH INTRAVENOUS CISPLATIN IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE CANCER AND LEUKEMIA GROUP-B, Journal of clinical oncology, 13(8), 1995, pp. 1871-1879
Authors:
MILLER AA
NIELL HB
GRIFFIN JP
Citation: Aa. Miller et al., PHASE-II STUDY OF PROLONGED ORAL ETOPOSIDE IN COMBINATION WITH INTRAVENOUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 12(1-2), 1995, pp. 59-65
Authors:
MILLER AA
HAMILTON CS
REID ALA
IRELAND MC
Citation: Aa. Miller et al., DELAYS IN DIAGNOSIS OF HEAD AND NECK-CANCER, Medical journal of Australia, 162(6), 1995, pp. 334-334
Authors:
THOMPSON DS
GRECO FA
MILLER AA
SRINIVAS NR
IGWEMEZIE LN
HAINSWORTH JD
SCHACTER LP
KAUL S
BARBHAIYA RH
GARROW GC
HANDE KR
Citation: Ds. Thompson et al., A PHASE-I STUDY OF ETOPOSIDE PHOSPHATE ADMINISTERED AS A DAILY 30-MINUTE INFUSION FOR 5 DAYS, Clinical pharmacology and therapeutics, 57(5), 1995, pp. 499-507
Authors:
MILLER AA
SAGER TW
Citation: Aa. Miller et Tw. Sager, SITE REDUNDANCY IN URBAN OZONE MONITORING, Journal of the Air & Waste Management Association [1995], 44(9), 1994, pp. 1097-1102
Authors:
MILLER AA
HARGIS JB
LILENBAUM RC
FIELDS SZ
ROSNER GL
SCHILSKY RL
Citation: Aa. Miller et al., PHASE-I STUDY OF TOPOTECAN AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 12(12), 1994, pp. 2743-2750
Authors:
MILLER AA
SALEWSKI E
Citation: Aa. Miller et E. Salewski, PROSPECTS FOR PIRARUBICIN, Medical and pediatric oncology, 22(4), 1994, pp. 261-268
Authors:
MILLER AA
TOLLEY EA
Citation: Aa. Miller et Ea. Tolley, PREDICTIVE PERFORMANCE OF A PHARMACODYNAMIC MODEL FOR ORAL ETOPOSIDE, Cancer research, 54(8), 1994, pp. 2080-2083
Authors:
MILLER AA
TOLLEY EA
Citation: Aa. Miller et Ea. Tolley, PREDICTIVE PERFORMANCE OF A PHARMACODYNAMIC MODEL FOR ORAL ETOPOSIDE (VOL 54, PG 2080, 1994), Cancer research, 54(15), 1994, pp. 4251-4251
Authors:
GLOVER D
LIPTON A
KELLER A
MILLER AA
BROWNING S
FRAM RJ
GEORGE S
ZELENAKAS K
MACERATA RS
SEAMAN JJ
Citation: D. Glover et al., INTRAVENOUS PAMIDRONATE DISODIUM TREATMENT OF BONE METASTASES IN PATIENTS WITH BREAST-CANCER - A DOSE-SEEKING STUDY, Cancer, 74(11), 1994, pp. 2949-2955
Authors:
MILLER AA
HOOPER SB
HARDING R
Citation: Aa. Miller et al., ROLE OF FETAL BREATHING MOVEMENTS IN CONTROL OF FETAL LUNG DISTENSION, Journal of applied physiology, 75(6), 1993, pp. 2711-2717
Authors:
MILLER AA
TOLLEY EA
NIELL HB
GRIFFIN JP
MAUER AM
Citation: Aa. Miller et al., PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1179-1188
Authors:
NEWMAN RA
PETERSON B
DAVEY FR
BRABYN C
COLLINS H
BRUNETTO VL
DUGGAN DB
WEISS RB
ROYSTON I
MILLARD FE
MILLER AA
BLOOMFIELD CD
Citation: Ra. Newman et al., PHENOTYPIC MARKERS AND BCL-1 GENE REARRANGEMENTS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY, Blood, 82(4), 1993, pp. 1239-1246
Authors:
ALVARADO M
BASS HN
CALDWELL S
JAMEHDOR M
MILLER AA
JACOB P
Citation: M. Alvarado et al., MILLER-DIEKER SYNDROME - DETECTION OF A CRYPTIC CHROMOSOME-TRANSLOCATION USING IN-SITU HYBRIDIZATION IN A FAMILY WITH MULTIPLE AFFECTED OFFSPRING, American journal of diseases of children [1960], 147(12), 1993, pp. 1291-1294
Risultati:
1-25
|